INS and Hypoglycemia: Therefore, we aimed to establish a hypoglycemia risk model for hospitalized patients with T2DM treated with intensive insulin therapy in China, identify the risk factors of hypoglycemia as soon as possible, and take active measures to reduce the incidence of hypoglycemia and improve the physical and mental health of such patients.